Farms.com Home   Farm Equipment News

Woods CRW and Merlo Announce Northeast Strategic Dealer Partnership

Merlo America has announced its newest partnership with Woods CRW, officially welcoming the dealership into its growing U.S. network. Woods CRW now offers Merlo’s full line of Italian-engineered telehandlers across all 4 dealership locations in Vermont, Pennsylvania, New York and Massachusetts to end-users across the Northeast. As an authorized Merlo America dealer, Woods CRW will provide full-service sales, rentals, parts and service support for the entire Merlo America lineup.

With one of the broadest ranges of telehandlers in the industry, Merlo offers solutions for nearly every application, including agriculture, construction, landscaping, utilities and more. A joint statement issued July 9 by the companies also notes that the hallmark of the Merlo line is its patented automatic attachment recognition system, which simplifies machine setup and optimizes performance based on the selected tool. As an official Merlo America dealer, Woods CRW can now offer customers direct access to these advanced machines, including expert product support and service.

Merlo machines are engineered with operator safety, comfort and productivity at the forefront. Each unit features a standard enclosed cab, high-visibility design and safety systems like the Adaptive Stability Control System (ASCS) and capacitive joystick controls – delivering an intuitive operating experience that puts power and precision in the operator’s hands.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.